Stock listing

Equillium, Inc.

Selected listing: EQ · NASDAQ · USD · US

Equillium, Inc. (NASDAQ:EQ), Health Technology. Latest release Oct 6, 2026: Equillium Announces Poster Presentation at the 50th Anniversary La Jolla…

EQ:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:EQ
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: NASDAQ
Currency: USD

About Equillium, Inc.

Equillium, Inc. is a public company traded under the ticker EQ in the American market. Equillium focuses on developing innovative therapies for autoimmune and inflammatory diseases.

Latest news from Equillium, Inc.

Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference

October 6, 2026

Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504

October 5, 2026

Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504

October 4, 2026

Equillium Announces Poster Presentations at the 7th International AHR Conference

September 28, 2026

Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum

September 16, 2026

All Equillium, Inc. news →

Research Equillium, Inc.

Equillium, Inc. company profile

View the public company page for Equillium, Inc. on 6ix.

Equillium, Inc. news

Read company news and market updates connected to Equillium, Inc..

Equillium, Inc. investor events

Find investor webinars, events, and replay context for Equillium, Inc..